Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
COCP similar filings
- 15 May 23 Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
- 24 Apr 23 Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
- 10 Apr 23 Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- 4 Apr 23 Other Events
- 15 Mar 23 Regulation FD Disclosure
- 9 Jan 23 Regulation FD Disclosure
- 26 Oct 22 Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
Filing view
External links
Exhibit 99.1